OXOS Medical announced a $23M Series A funding from Parkway Venture Capital and Intel Capital, bringing its total funding to $45 million.

OXOS will use the funding to accelerate product innovation and expand availability globally. OXOS continues to build on its traction across outpatient clinics, the military, the Veterans Administration, sports teams, hospitals, imaging centers, and bioskills labs.